Bioline RX Ltd Sponsored ADR (BLRX)
NASDAQ:BLRX
Holding BLRX?
Track your performance easily

Bioline RX Ltd Sponsored ADR (BLRX) Income Statement

2,390 Followers

Bioline RX Ltd Sponsored ADR Income Statement

Last quarter (Q4 2023), Bioline RX Ltd Sponsored ADR's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Bioline RX Ltd Sponsored ADR's net income was $―. See Bioline RX Ltd Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-$ 4.80M--$ -1.63M-
Cost of Revenue
-$ 3.69M----
Gross Profit
-$ 1.11M--$ -1.63M-
Operating Expense
$ 14.68M$ 50.80M$ 31.32M$ 25.78M$ 22.93M$ 30.39M
Operating Income
$ -14.68M$ -49.70M$ -31.32M$ -25.78M$ -24.56M$ -30.39M
Net Non Operating Interest Income Expense
$ -457.00K$ -162.00K$ 694.00K$ 559.00K$ 236.00K$ 777.00K
Other Income Expense
$ 847.00K$ 10.82M$ -22.77M$ -50.41M$ -19.25M$ -20.30M
Pretax Income
$ -14.29M$ -60.62M$ -30.62M$ -25.22M$ -24.32M$ -29.61M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -14.29M$ -60.62M$ -24.95M$ -27.05M$ -30.02M$ -25.45M
Basic EPS
$ -0.30$ -0.06$ -0.03$ -0.04$ -0.12$ -0.17
Diluted EPS
$ -0.30$ -0.06$ -0.03$ -0.04$ -0.12$ -0.17
Basic Average Shares
$ 97.08M$ 963.37M$ 773.96M$ 662.93M$ 252.84M$ 146.41M
Diluted Average Shares
$ 97.08M$ 963.37M$ 831.70M$ 662.93M$ 252.84M$ 146.41M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 14.68M$ 54.49M$ 31.32M$ 25.78M$ 22.93M$ 30.39M
Net Income From Continuing And Discontinued Operation
$ -14.29M$ -60.62M$ -24.95M$ -27.05M$ -30.02M$ -25.45M
Normalized Income
$ -14.29M-----
Interest Expense
$ 646.00K-----
EBIT
$ -13.64M-$ -32.41M$ -26.21M$ -24.32M$ -29.61M
EBITDA
$ -13.35M-$ -33.02M$ -26.87M$ -25.18M$ -30.47M
Currency in USD

Bioline RX Ltd Sponsored ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis